Beaufort Securities reissued their speculative buy rating on shares of Oncimmune Holdings PLC (LON:ONC) in a research note published on Tuesday.

Oncimmune Holdings PLC (LON:ONC) opened at 110.00 on Tuesday. The company’s market capitalization is GBX 467500.00. Oncimmune Holdings PLC has a one year low of GBX 105.00 and a one year high of GBX 140.00. The firm’s 50-day moving average price is GBX 116.92 and its 200 day moving average price is GBX 119.99.

About Oncimmune Holdings PLC

Oncimmune Holdings plc is a United Kingdom-based cancer detection company. The Company is engaged in developing and commercializing its EarlyCDT platform technology. The Company is involved in the development of tests based on the presence in the blood of autoantibodies against specific tumor associated antigens (TAAs) that can detect cancer till approximately four years earlier than other methods, such as a chest X-ray or spiral computed tomography (CT), and is applied to a range of tumor types.

Receive News & Stock Ratings for Oncimmune Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune Holdings PLC and related stocks with our FREE daily email newsletter.